The infusion of Omegaven can cause prolonged bleeding time and an inhibited platelet aggregation. Therefore, Omegaven should be administered with caution to patients requiring anticoagulant therapy even with regard to a possible reduction of anticoagulants.
Incompatibilities: Incompatibilities may occur through the addition of polyvalent cations eg, calcium, especially when combined with heparin.